Trials / Unknown
UnknownNCT05576402
Endoscopic Scoring System Utilization in Inflammatory Bowel Disease
Endoscopic Scoring System Utilization for Inflammatory Bowel Disease Activity Assessment
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Inflammatory bowel diseases comprise two distinctive entities: Crohn's disease and ulcerative colitis. During the last decade, endoscopic assessment of inflammation has become relevant since it is a prognostic factor. As a consequence, therapeutic targets now contemplate mucosal healing as part of the goals to be achieved. Endoscopic scores for Crohn's disease and ulcerative colitis have been developed to objectively assess the mucosal inflammatory activity. Although they may have some limitations, these scores have been widely accepted in referral centers, especially since they have been adopted as standard evaluation in inflammatory bowel disease clinical trials . However, their use in the setting of endoscopic practice outside centers with a high volume or with less experience in clinical trials is not known.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | colonoscopy | endoscopic exploration of colonic mucosa to evaluate inflammatory activity in patients with either Crohn's disease or ulcerative colitis |
Timeline
- Start date
- 2022-05-02
- Primary completion
- 2023-01-31
- Completion
- 2023-02-20
- First posted
- 2022-10-12
- Last updated
- 2022-12-28
Locations
1 site across 1 country: Argentina
Source: ClinicalTrials.gov record NCT05576402. Inclusion in this directory is not an endorsement.